These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3060835)

  • 1. Comparison of penetration-enhancing ability of laurocapram, N-methyl-2-pyrrolidone and dodecyl-L-pyroglutamate.
    Príborský J; Takayama K; Nagai T; Waitzová D; Elis J; Makino Y; Suzuki Y
    Pharm Weekbl Sci; 1988 Oct; 10(5):189-92. PubMed ID: 3060835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination effect of penetration enhancers and propylene glycol on in vitro transdermal absorption of insulin.
    Príborský J; Takayama K; Nagai T; Waitzová D; Elis J
    Drug Des Deliv; 1987 Dec; 2(2):91-7. PubMed ID: 3334547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of alkyl-substituted pyrrolidone derivatives and their evaluation as transdermal penetration enhancers.
    Aoyagi T; Yamamura M; Suzuki N; Matsui K; Nagase Y
    Drug Des Discov; 1991 Nov; 8(1):37-46. PubMed ID: 1810410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of in-vitro percutaneous absorption across human skin and in animal models.
    Príborský J; Mühlbachová E
    J Pharm Pharmacol; 1990 Jul; 42(7):468-72. PubMed ID: 1980285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of topical laurocapram (Azone) on the in vitro percutaneous permeation of sodium lauryl sulfate using human skin.
    Szolar-Platzer C; Patil S; Maibach HI
    Acta Derm Venereol; 1996 May; 76(3):182-5. PubMed ID: 8800295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport.
    Lee PJ; Langer R; Shastri VP
    J Pharm Sci; 2005 Apr; 94(4):912-7. PubMed ID: 15736187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicokinetics and metabolism of N-[(14)C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: in vivo and in vitro percutaneous absorption.
    Payan JP; Boudry I; Beydon D; Fabry JP; Grandclaude MC; Ferrari E; André JC
    Drug Metab Dispos; 2003 May; 31(5):659-69. PubMed ID: 12695356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder.
    Sun F; Sui C; Zhou Y; Liu X; Shi Y; Wu Y; Li Y
    Int J Pharm; 2013 Sep; 454(1):532-8. PubMed ID: 23891744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous penetration of fluorescein isothiocyanate-dextrans and the mechanism for enhancement effect of enhancers on the intercellular penetration.
    Ogiso T; Paku T; Iwaki M; Tanino T
    Biol Pharm Bull; 1995 Nov; 18(11):1566-71. PubMed ID: 8593481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of percutaneous absorption by laurocapram.
    Ogiso T; Iwaki M; Bechako K; Tsutsumi Y
    J Pharm Sci; 1992 Aug; 81(8):762-7. PubMed ID: 1328599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of topical formulations of morphine hydrochloride containing azone and N-methyl-2-pyrrolidone.
    Sugibayashi K; Sakanoue C; Morimoto Y
    Sel Cancer Ther; 1989; 5(3):119-28. PubMed ID: 2814004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations of pharmacokinetics and pharmacodynamics of a combined preparation containing pyrrolidone and pyroglutamic acid].
    Sariev AK; Lun'shina EV; Zherdev VP; Mirzoian NR
    Eksp Klin Farmakol; 2006; 69(2):58-61. PubMed ID: 16845944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing effect of combining two pyrrolidone vehicles on transdermal drug delivery.
    Sasaki H; Kojima M; Nakamura J; Shibasaki J
    J Pharm Pharmacol; 1990 Mar; 42(3):196-9. PubMed ID: 1974617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol.
    Koizumi A; Fujii M; Kondoh M; Watanabe Y
    Eur J Pharm Biopharm; 2004 May; 57(3):473-8. PubMed ID: 15093595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing effect of N-dodecyl-2-pyrrolidone on the percutaneous absorption of 5-fluorouracil derivatives.
    Sato S; Hirotani Y; Ogura N; Sasaki E; Kitagawa S
    Chem Pharm Bull (Tokyo); 1998 May; 46(5):831-6. PubMed ID: 9621418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of counter-ions and penetration enhancers on the skin permeation of flurbiprofen.
    Ma X; Fang L; Guo J; Zhao N; He Z
    J Pharm Sci; 2010 Apr; 99(4):1826-37. PubMed ID: 19894269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of limonene and laurocapram on percutaneous absorption of nonsteroidal anti-inflammatory drugs.
    Priborský J; Takayama K; Obata Y; Príborská Z; Nagai T
    Arzneimittelforschung; 1992 Feb; 42(2):116-9. PubMed ID: 1610418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of solvents on skin permeation of formoterol fumarate.
    Kakubari I; Nakamura N; Takayasu T; Yamauchi H; Takayama S; Takayama K
    Biol Pharm Bull; 2006 Jan; 29(1):146-9. PubMed ID: 16394528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker.
    Jönsson BA; Akesson B
    Int Arch Occup Environ Health; 2003 May; 76(4):267-74. PubMed ID: 12684812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism.
    Ligocka D; Lison D; Haufroid V
    Arch Toxicol; 2003 May; 77(5):261-6. PubMed ID: 12734639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.